In an orthologous autosomal dominant polycystic kidney disease (ADPKD) mouse model, knockout of NRF2 further increased ROS generation and promoted cyst growth, while pharmacological induction of NRF2 reduced ROS production, slowed cystogenesis, and slowed disease progression [98]. The gene discussed is NFE2L2; the disease is autosomal dominant polycystic kidney disease.